(Reuters) - The U.S. Centers for Disease Control and Prevention has accepted its advisory panel's recommendations on vaccines ...

The EMA now advises against using the drug for people aged over 65 after 17 serious adverse effects were recorded in this age ...

CHIKV can trigger long-term joint pain that mimics autoimmune diseases like rheumatoid arthritis, potentially due to ...

JEYPORE: District health administration is on high alert after at least 23 residents of Rathasharma colony in Koraput town ...

The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...

The FDA and CDC are recommending a pause on the use of Ixchiq (chikungunya vaccine, live) in patients 60 years and older during an ongoing safety investigation.

The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...

Mosquitoes can tranmist dengue virus, which has already caused local cases in Florida in 2025... | Clinical And Molecular Dx ...

FDA and CDC recommend halting Ixchiq vaccine use in adults 60 and older after reports of serious adverse events, including ...

Bhopal: In Madhya Pradesh, chikungunya cases have risen significantly, matching the increase in dengue infections, creating ...

A new study published Thursday warns that tiger mosquitoes are increasingly spreading to Europe because of climate change, ...

The U.S. Centers for Disease Control and Prevention accepted its advisory panel's recommendations on vaccines for chikungunya ...